A 12 Month, Open-label, Multi-center Trial to Investigate the Endometrial Safety of Vagifem Low Dose (10ug 17beta-estradiol Vaginal Tablet) in Postmenopausal Women With Atrophic Vaginitis Symptoms.
Phase of Trial: Phase III
Latest Information Update: 17 Mar 2017
At a glance
- Drugs Estradiol (Primary)
- Indications Atrophic vaginitis
- Focus Adverse reactions; Registrational
- Sponsors Novo Nordisk
- 03 Jul 2012 Planned number of patients changed from 325 to 530 as reported by European Clinical Trials Database.
- 01 Dec 2008 Actual patient number reported as 335 by ClinicalTrials.gov.
- 01 Dec 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.